PTPRG and Miyoshi myopathy: Our demonstration that high PTPRG expression marks the stem‐like, drug‐resistant MalPlasma3 subcluster and that its knockdown impairs proliferation while promoting apoptosis unveils a previously unrecognized function for PTPRG in MM and positions it as both a novel prognostic biomarker and a tractable target for therapy.